Researcher Profiles

Resident Members

Search by Name (RESIDENT MEMBERS)

Last Name: and/or First Name:

A | B | C | D | F | G | H | I | J | K | L | M | N | P | R | S | T | W | X | Y | Z | Show All

Joseph Aisner, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

David A. August, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Elisa V. Bandera, MD, PhD
Full Member,
Cancer Prevention and Control Program

Debabrata Banerjee, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Rajat Bannerji, MD, PhD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Joseph R. Bertino, MD
Full Member,
Cancer Pharmacology Program

Mantu Bhaumik, PhD
Advisory Member,
Program: non-aligned

Darren R. Carpizo, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program,
Cancer Pharmacology Program

Chang S. Chan, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Ting Chen, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Karine A. Cohen-Solal, PhD
Full Member,
Cancer Metabolism and Growth Program

Alan Cohler, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Elliot J. Coups, PhD
Full Member,
Cancer Prevention and Control Program

Kevin A. David, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Katie Devine, PhD, MPH
Associate I Member,
Cancer Prevention and Control Program

Robert S. DiPaola, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Richard A. Drachtman, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Zhaohui Feng, MD, PhD
Full Member,
Cancer Metabolism and Growth Program

David J. Foran, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Molly Gabel, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Shridar Ganesan, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Mecide M. Gharibo, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Darlene G. Gibbon, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Susan Goodin, PharmD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Sharad Goyal, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

James S. Goydos, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

John J. Graff, PhD, MS
Associate II Member,
Cancer Prevention and Control Program

Bruce G. Haffty, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Mira Hellman, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Kim M. Hirshfield, MD, PhD
Associate I Member,
Genome Instability and Cancer Genetics Program

Wenwei Hu, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Sara S. Isani, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Salma Jabbour, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Howard L. Kaufman, MD, FACS
Full Member,
Clinical Investigations and Precision Therapeutics Program

Thomas J. Kearney, MD, FACS
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

John E. Kerrigan, PhD
Associate II Member,
Cancer Pharmacology Program

Atif J. Khan, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Isaac Yi Kim, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Leonard H. Kim, MS, AMusD, DABR
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sung Kim, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Laurie J. Kirstein, MD, FACS
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Vadim Koshenkov, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

John E. Langenfeld, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Edmund C. Lattime, PhD
Full Member,
Cancer Metabolism and Growth Program

Pauline Lerma, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Arnold Levine, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Jocelyn A. Lewis, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Grace L. Lu-Yao, PhD, MPH
Full Member,
Cancer Prevention and Control Program

Omar M. Mahmoud, MD, MSc, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sharon L. Manne, PhD
Full Member,
Cancer Prevention and Control Program

Margaret Masterson, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Tina M. Mayer, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Michael McKenna, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Daniel J. Medina, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Janice M. Mehnert, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Tricia Morino, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Rebecca Moss, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Sabin Motwani, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Susan M. Murphy, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Venkat Narra, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Ke Nie, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Wilbur Pan, MD, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Vimal D. Patel, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sharon R. Pine, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Elizabeth A. Poplin, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Lorna Rodriguez-Rodriguez, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Hatem E. Sabaawy, MD, PhD
Full Member,
Cancer Pharmacology Program

Biren Saraiya, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Dale G. Schaar, MD, PhD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Kathleen W. Scotto, PhD
Full Member,
Cancer Pharmacology Program

Archana Sharma, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Zhiyuan Shen, MD, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Weichung (Joe) Shih, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Eric A. Singer, MD, MA
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Rachana Singh, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Jerod Stapleton, PhD
Full Member,
Cancer Prevention and Control Program

Mark N. Stein, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Roger K. Strair, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Antoinette (Nan) M. Stroup, PhD
Full Member,
Cancer Prevention and Control Program

Sujani G. Surakanti, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

XiangLin Tan, MD, PhD
Associate I Member,
Cancer Prevention and Control Program

Deborah L. Toppmeyer, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Jennifer Tsui, PhD, MPH
Associate II Member,
Cancer Prevention and Control Program

Robert E. Weiss, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Eileen White, PhD
Full Member,
Cancer Metabolism and Growth Program

Serena Wong, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Bing Xia, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Ning Jeff Yue, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Miao Zhang, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

X. F. Steven Zheng, PhD
Full Member,
Cancer Pharmacology Program

Hua Zhong, MD, PhD, FCAP
Advisory Member,
Clinical Investigations and Precision Therapeutics Program

Wei (Jennifer) Zou, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program